Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Undeserved Neighborhoods in Indianapolis.

Eli Lilly and Company (NYSE: LLY) and Indiana University’s Richard M. Fairbanks School of Public Health at IUPUI announced today the launch of a new neighborhood-based, data-driven pilot in Indianapolis to help address the high incidence of diabetes. Building on similar efforts Lilly has developed in lower-income communities in Mexico, India and South Africa, the $7 million, five-year program will focus on three Indianapolis neighborhoods with significant health disparities and high rates of diabetes: the Coalition of Northeast Neighborhoods, Northwest Neighborhood and Near Westside Neighborhood.

Life expectancy in these three communities can be 14 years lower than in neighborhoods just 10 miles away. The lower life expectancy rate is largely due to health disparities and is similar to rates seen in countries such as Iraq and Bangladesh.

This pilot in Indianapolis neighborhoods will target people with diabetes or at risk for the disease. The three communities were selected based on high prevalence of diabetes, socio-economic factors and highly engaged community members and organizations.

Globally, 425 million people have diabetes, with a prevalence rate of 8.4 percent. In the three target neighborhoods in Indianapolis, an estimated 10,000 people live with diabetes, and prevalence rates are as high as 17.5 percent.

About Eli Lilly and Company
Lilly is a global health care leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/newsroom/social-channels. CR-LLY

About IU Richard M. Fairbanks School of Public Health at IUPUI
Committed to advancing the public’s health and well-being through education, innovation and leadership, the IU Richard M. Fairbanks School of Public Health is known for its expertise in biostatistics, epidemiology, cancer research, community health, environmental public health, health policy and health administration. As Indiana’s premier urban research and health sciences institution, IUPUI (Indiana University-Purdue University Indianapolis) is home to over 30,000 students and offers more than 300 Indiana University and Purdue University undergraduate, graduate and professional degree programs. IUPUI is dedicated to advancing the intellectual growth of Indiana through research and creative activity, teaching, learning, and community engagement.

For more information visit : https://investor.lilly.com/news-releases/news-release-details/lilly-and-local-partners-launch-diabetes-prevention-and

 

Leave a Reply

Your email address will not be published.

Chat with us
Loading...